JO
MEDP icon

John Overdeck’s Medpace MEDP Stock Holding History

John Overdeck’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,600
Closed -$471K – 3560
2019
Q4 		$471K Sell
5,600
-2,800
-33% -$217K ﹤0.01% 2846
2019
Q3 		$706K Buy
+8,400
New +$635K ﹤0.01% 2272

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

John Overdeck's MEDP Position: Q2 2026 in Review

John Overdeck reduced its Medpace (MEDP) stake by 94% in Q2 2026, selling an estimated $77M and leaving 9,740 shares worth $5.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2116.

John Overdeck first reported a position in MEDP in Q3 2016 and has held it in 27 quarters since. The position peaked at $84.8M in Q1 2026. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • John Overdeck held 9,740 shares of Medpace worth $5.16M as of Q2 2026.
  • John Overdeck sold 166,817 Medpace shares in Q2 2026, an estimated $77M.
  • Medpace made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2116 holding.
  • John Overdeck first reported a position in Medpace in Q3 2016 and has held it in 27 quarters since.
  • John Overdeck's Medpace position peaked at $84.8M in Q1 2026.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.